Patents
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
05/2007
05/22/2007US7220734 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles as Edg receptor agonists
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2006099058A3 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use
05/18/2007WO2006081807A3 Method for the production of losartan
05/18/2007CA2627719A1 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070111274 Alkali metal or ammonium salts of sulfonated 3-(p-phenylazophenyl)-2,5-diphenyl-2H-tetrazolium compounds; quantitative analysis of dehydrogenase
05/16/2007CN1964955A Small molecules for treatment of hypercholesterolemia and related diseases
05/16/2007CN1962596A Ketone compounds and compositions for cholesterol management and related uses
05/15/2007US7217825 Neutralizing an acidified solution of a water-miscible solvent and 2-butyl-3-[2'-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl methyl]-1,3-diazaspiro[4.4]non-1-ene-4-one, a novel intermediate of a Suzuki coupling reaction; acidifying and cooling the second solution and recovering irbesartan
05/15/2007US7217728 For therapy of reperfusion injury
05/10/2007WO2007009637A3 Complexes containing perfluoroalkyl, their use as contrast media for nmr, x-ray and radio diagnosis and radiotherapy
05/10/2007WO2006120574A3 Analogs of 4-hydroxyisoleucine and uses thereof
05/10/2007WO2006002873A3 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri )
05/10/2007US20070106080 Process for production of 1-aryl-5-(trifluoromethyl)-1h-tetrazoles
05/10/2007US20070105958 Compounds for the treatment of metabolic disorders
05/10/2007US20070105926 Tetrazoyloxime derivative and agricultural chemical containing the same as active ingredient
05/10/2007US20070105924 Vigabatrin bioisoteres and related methods of use
05/10/2007US20070105858 Retinoic acid mimetic anilides
05/09/2007EP1781627A2 A method for preparing irbesartan and intermediates thereof
05/09/2007CN1314672C 5-substituted aromatic laydrocarbon tetrazole production method
05/08/2007US7214545 Element-coded affinity tags
05/08/2007CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/03/2007WO2007048771A1 Arylurea derivatives as modulators of chemokine receptor activity
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/03/2007US20070098643 Oligomers of gadolinium chelates, their applicationascontrast products in magnetic resonance imaging and their synthesis intermediates
05/03/2007CA2626324A1 Arylurea derivatives as modulators of chemokine receptor activity
05/02/2007EP1778651A2 Multivalent chelators for modifying and organizing of target molecules
05/02/2007EP1778650A1 Process for preparing candesartan cilexetil
05/02/2007EP1480979B1 Gadolinium chelate oligomers, their use as contrast products in magnetic resonance imaging and their synthesis intermediates
05/02/2007EP1115693B1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
05/01/2007US7211241 Cascade polymer complexes that contain complexing ligands of general formula I A-(X (Y-(Z-(W KW)Z)y)x) (I), in which A stands for a nitrogen-containing cascade nucleus of base multiplicity a, X and Y, independently of one another, stand
05/01/2007CA2138675C Catecholamine surrogates useful as .beta.3 agonists
04/2007
04/26/2007WO2007047447A2 Diuretic-like compound analogs useful for regulation of central nervous system disorders
04/26/2007WO2007045675A1 Process for obtaining valine derivatives useful for obtaining a pharmaceutically active compound
04/26/2007WO2007045370A1 Tetrazol derivatives and their use for the treatment of cardiovascular diseases
04/26/2007WO2007045369A1 Difluorophenol derivatives and their use
04/26/2007WO2007017267A3 Novel compounds
04/26/2007WO2007009638A3 Complexes containing perfluoroalkyl, method for the production and use thereof
04/26/2007WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions
04/26/2007US20070093542 Process for the preparation of valsartan and intermediates thereof
04/26/2007US20070093487 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
04/26/2007DE112005001305T5 Gaserzeugungsmittel und Synthese And synthesis gas generating agent
04/26/2007DE102005050497A1 Difluorphenol-Derivate und ihre Verwendung Difluorophenol derivatives and their use
04/26/2007DE102005050375A1 Tetrazol-Derivate und ihre Verwendung Tetrazole derivatives and their use
04/26/2007CA2625918A1 Diuretic-like compound analogs useful for regulation of central nervous system disorders
04/25/2007EP1777224A2 A process for the preparation of angiotensin II antagonistic compounds
04/25/2007CN1953966A Anticancer agent
04/24/2007USRE39590 3-(4-chloro-6-fluoro-3-methoxy-2-nitrophenyl)-6-trifluoromethyl-2,4(1H, 3H)-pyrimidinedione; useful for general or pre-emergent or post-emergent control of undesired plant species and defoliants at very low concentrations
04/24/2007US7208140 Trimeric macrocyclic substituted benzene derivatives
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007044724A2 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
04/19/2007WO2007042506A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
04/19/2007US20070088004 MAO-B inhibitors useful for treating obesity
04/19/2007CA2625207A1 Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
04/19/2007CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3
04/18/2007EP1773792A1 Indanone potentiators of metabotropic glutamate receptors
04/18/2007EP1773125A1 5-iodotetrazoles
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007CN1310905C Antivirally active heterocyclic azahexane derivatives
04/18/2007CN1310642C Methods and compositions to enhance white blood cell count
04/17/2007US7205267 Use of transition metal complexes as bleach catalysts in laundry detergents and cleaning compositions
04/11/2007EP1307237B1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
04/11/2007EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/10/2007US7202367 Process for arylating or vinylating or alkynating a nucleophilic compound
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/05/2007WO2007037685A1 Novel antibiotics comprising bis(1-aryl-5-tetraz0lyl)methane derivatives
04/04/2007EP1769796A1 Novel antibiotics comprising bis(1-aryl-5-tetrazolyl)methane derivatives
04/04/2007CN1308297C Phenyl sulfamate derivatives
04/04/2007CN1307992C Eye drops containing tetrazole derivative
04/03/2007US7199144 Containing less than about 5000 ppm residual solvent by trituration in water
03/2007
03/29/2007WO2007035964A2 Vigabatrin bioisoteres and related methods of use
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007US20070072923 Process for producing 2'-(1h-tetrazol-5-yl)biphenyl-4-carbaldehyde
03/29/2007US20070072922 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
03/29/2007US20070072909 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
03/29/2007US20070072900 P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
03/29/2007CA2623312A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/28/2007EP1765826A2 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles
03/28/2007EP1765812A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents
03/28/2007EP1765332A2 Trisubstituted nitrogen modulators of tyrosine phosphatases
03/28/2007EP0988305B1 A PROCESS FOR THE PREPARATION OF 5H,9bH-2a, 4a,7,9a-OCTAHYDROTETRAAZACYCLOOCTA [cd] PENTALENE
03/28/2007CN1938266A Sulfonamide compounds for the treatment of neurodegenerative disorders
03/27/2007CA2326611C Substituted heterocyclic derivatives
03/22/2007WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/22/2007US20070066819 Process for the preparation of benzotriazepine derivatives
03/22/2007US20070066586 Aniline derivatives
03/22/2007CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
03/22/2007CA2619955A1 Process for preparing valsartan
03/21/2007CN1931857A Prepn process of 5-losartan carboxylate
03/20/2007US7192982 Modulators of peroxisome proliferator activated receptors
03/15/2007WO2007029587A1 β SECRETASE INHIBITOR
03/15/2007WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/15/2007WO2007029021A1 1,5-substituted tetrazoles as therapeutic compounds
03/15/2007WO2006050444A9 Water-based synthesis of poly(tetrazoles)
03/15/2007US20070060630 Producing an alkoxy(tetrazol-1-yl)benzaldehyde compound by reacting the corresponding 1-(alkoxyphenyl)-1H-tetrazole compound with hexamethylenetetramine in a sulfonic acid' solvent, followed by hydrolysis; safe, efficient process; intermediate for analgesics or anti-inflammatory agents
03/15/2007US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
03/15/2007CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors
03/14/2007CN1930153A Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
03/14/2007CN1304381C Chemical synthesis method of 1,2,3,4-tetra nitroazole kind compound
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 97